Lineage Cell Therapeutics Inc logo

Lineage Cell Therapeutics Inc

NEW
STU:BT3 (USA)  
€ 0.93 -0.026 (-2.71%) Jul 31
At Loss
P/B:
5.00
Market Cap:
€ 233.66M ($ 269.56M)
Enterprise V:
€ 188.39M ($ 217.34M)
Volume:
4.00
Avg Vol (2M):
4.00
Trade In:
Volume:
4.00
At Loss

Lineage Cell Therapeutics Inc (STU:BT3) Dividend

Lineage Cell Therapeutics Inc (STU:BT3) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -12.6%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:BT3 Dividend

Does Lineage Cell Therapeutics Inc (STU:BT3) pay a dividend?

Lineage Cell Therapeutics Inc (STU:BT3) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Lineage Cell Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Lineage Cell Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -12.6% over the past 3 years.

What are dividend-paying alternatives to Lineage Cell Therapeutics Inc?

For dividend-paying alternatives in Lineage Cell Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.